skip to context

Adis – a leading provider of drug information globally

A trusted and reputable publisher for over 40 years, Adis offers your end-users valuable and unique journal, and newsletter content, featuring highly used and cited content - an invaluable source of information for anyone involved in medical research, practice or teaching, drug regulation or reimbursement, or any part of the pharmaceutical industry

Reputable and independent
  • Adis content is thoroughly peer reviewed
  • More than 40 years’ experience publishing medical journals with a reputation for excellence, many with high Impact Factors
  • Many Adis journals utilize independent, in-house and specialist-area expert Editors-in-Chief to guide journal content based on reader interest and scientific merit, while other journals in the portfolio may have external Editors-in-Chief supported by in-house Editors
Valuable content for end-users
  • Authoritative, time-saving reviews of complex clinical and specialist data
  • Rapid dissemination of important original research
  • Comprehensive single-agent Adis Drug Reviews, written by highly experienced in-house writers
  • Digital features to facilitate reader understanding (such as summary slides, videos, animations, slide decks and audio slides) and plain language summaries to extend the reach of content to other audiences
Available on Springer Nature's leading research platforms
  • SpringerLink and Springer for R&D, including Springer for Hospitals & Health and Springer for Pharma and biotechnology
  • Robust, mobile-optimized platforms
  • Access to over 8 million research documents, including thousands of eBooks and more than 400 relevant medical journals
Open Access

Adis publishes a number of fully open access journals, available alongside the subscribed content on Springer’s global platforms. All Adis subscription journals offer the option to publish individual open access articles through Springer OpenChoice.

Adis online journal archive

An invaluable archival resource for our global audience. Adis has been publishing high quality journals, focusing on translating research into clinical practice, for over 40 years. Your institution can now have full, uninterrupted access to the Adis Journal Archive on the Springer platforms, through a one-off purchase.

Archive coverage

  • American Journal of Cancer 2002-2006
  • American Journal of Drug Delivery 2003-2006
  • Applied Bioinformatics 2004-2006
  • BioDrugs (formerly Clinical Immunotherapeutics) 1994 –1996
  • Clinical Drug Investigation (including predecessor Drug Investigation) 1989 –1996
  • Clinical Pharmacokinetics 1976 –1996
  • CNS Drugs 1994 –1996
  • Disease Management and Health Outcomes 1997-2008
  • Drug Safety (including predecessor Medical Toxicology and Adverse Drug Experience) 1986 –1996
  • Drugs 1971–1996
  • Drugs & Aging 1991–1996
  • Drugs & Therapy Perspectives 1993 –1996
  • Evidence-based Integrative Medicine 2003 - 2005
  • Inpharma Weekly 1975 – 1998
  • Pharmaceutical & Diagnostic Innovation (including predecessor Pharmaceutical Innovation) 2001 – 2006
  • Pharmaceutical Development & Regulation 2003 - 2003
  • PharmacoEconomics 1992 –1996
  • PharmacoEconomics & Outcomes News Weekly (including predecessor Pharmacoresources) 1994 –1996
  • Reactions Weekly 1980 –1996
  • Sports Medicine 1984 – 1996
  • Toxicological Reviews (including predecessor Adverse Drug Reactions & Toxicological Reviews) 2002-2006
  • Treatments in Endocrinology 2002-2006
  • Treatments in Respiratory Medicine (including predecessor American Journal of Respiratory Medicine) 2002-2006 
  • Business

    Products & services

    Discover AdisInsight, our journals, newsletters and books, and our pharmacovigilance solutions

  • View a demo R&D

    Resources for Librarians

     Access a host of information on Springer content solutions, services and offers for librarians

  • Custom Intelligence

    Adis Drug Reviews

    Learn more about our Adis Drug Evaluations, AdisInsight Reports and Adis Drug Q&As